Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 298
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously...
Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in...
MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...
MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on...
Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device
Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment...
MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...
Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome...
The Problem and Paradox of Bad Trips – Part 1
Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE...
Load more